Research Papers
Campbell JD, Gries KS, Watanabe JH, Ravelo A, Dmochowski RR, Sullivan SD. Treatment success for overactive bladder with urinary urge incontinence refractory oral antimuscarinics. BMC Urol. 2009 Nov 20;9:18.
Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology. 2010 Oct;76(4):835-40.
Sand P, Rovner E, Dmochoswki R, Watanabe JH, Oefelein MG. Once-daily trospium chloride 60 mg extended release is safe and effective in subjects with the overactive bladder syndrome who use multiple concomitant medications. Drugs and Aging. 2011. 28(2):151-160.
Patel VP, Watanabe JH, Strauss J, Dubey A. Work productivity loss in patients with dry eye disease: an online survey. Current Medical Research and Opinion. 2011. 27(5):1041-1048.
Watanabe JH, Ney JP. Once-daily generic anticholinergics for overactive bladder: meta-analysis of oxybutynin extended-release randomized trials. Am J Pharm Benefits. 2011;3(5):e85-e92.
Ney JP, van der Goes DN, Watanabe JH. Cost-effectiveness of intraoperative neurophysiological monitoring for spinal surgeries: beginning steps. ClinNeurophysiol. 2012 Sep;123(9):1705-7. doi: 10.1016/j.clinph.2012.01.020. Epub 2012 Mar 3. PubMed PMID: 22386320.
Watanabe JH, Bounthavong M, Chen T. Revisiting the medication possession ratio
threshold for adherence in lipid management. Curr Med Res Opin. 2013
Mar;29(3):175-80. doi: 10.1185/03007995.2013.766164. Epub 2013 Feb 1. PubMed
PMID: 23320610.
Ney JP, van der Goes DN, Watanabe JH. Cost-Benefit Analysis: Intraoperative
Neurophysiologic Monitoring in Spinal Surgeries. J ClinNeurophys. 2013
Jun;30(3):280-6. doi: 10.1097/WNP.0b013e3182933d8f. PubMed PMID: 23733093.
Ney JP, Devine EB, Watanabe JH, Sullivan SD. Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons. Pain Med. 2013 May;14(5):706-19. doi: 10.1111/pme.12091. Epub 2013 Apr 22. PubMed PMID: 23691937.
Kazerooni R, Watanabe JH, Bounthavong M. Association Between Statin Adherence and Cholesterol Level Reduction from Baseline in a Veteran Population. Pharmacotherapy. 2013 Jun 6.doi: 10.1002/phar.1305. [Epub ahead of print] PubMed PMID: 23744794.
Kazerooni R, Bounthavong M, Watanabe JH. Effect of copayment on statin adherence analyzed by socioeconomic status. Ann Pharmacother 1060028013505743, first published on October 10, 2013 as doi:10.1177/1060028013505743.
Watanabe JH, Bounthavong M, Chen T, Ney JP. Association of polypharmacy and statin new user adherence in a veterans affairs population: a retrospective cohort study. Ann Pharmacother 1060028013502000, first published on October 21, 2013 as doi:10.1177/1060028013502000
Watanabe JH, Kazerooni R, Bounthavong M. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study. JMCP.
Accepted.
Abstracts
Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD. Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder.Podium Session. American Urological Association Annual Meeting April 2008.
Campbell JD, Watanabe JH, Sullivan SD. Smoking and asthma: the additional asthma burden associated with current smokers. Poster Session. International Society of Pharmacoeconomics and Outcomes Research Asia-Pacific Conference September 2008.
Rovner E, Dmochowski, R, Watanabe J. Once-daily trospium chloride 60 mg extended release is safe and effective in patients with the overactive bladder syndrome who use multiple concomitant medications. Poster Session. Society for Urodynamics and Female Urology Winter Meeting February 2009.
Watanabe JH, Campbell JD, Ravelo A, Chancellor MB, Kowalski J, Sullivan SD. Three-year cost analysis of sacral neuromodulation, intra-detrusor injection of botulinum toxin type a and augmentation cystoplasty for overactive bladder. Moderated Poster Session. American Urological Association Annual Meeting May 2009.
Gries KG, Campbell JD, Watanabe JH, Dmochowski R, Sullivan SD. Characterization of treatment success for overactive bladder in urinary urge incontinence refractory to oral antimuscarinics. Moderated Poster Session. American Urological Association Annual Meeting May 2009.
Watanabe J, Patel V, Oefelein M. Quantifying at risk population in chronic overactive bladder medication users in a US claims database. Poster Session. Academy of Managed Care Pharmacy Educational Conference October 2010.
Dubey A, Patel V, Strauss J, Watanabe J. Productivity loss in dry eye disease patients: an on-line survey. Association for Research in Vision and Opthalmology. Poster Session. May 2010.
Watanabe JH. Improving management of overactive bladder with novel treatment paradigms: localized versus systemic therapy. Continuing medical education program. May 2010.
Ney JP, Watanabe JH. US pharmaceutical expenditures- trends for peripheral neuropathic pain, 1997-2007. American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting. Poster session. October 2010.
Watanabe JH, Ney JP. Association of access to medications and health care utilization: impact on risk of emergency room visit for those unable to obtain medications. Poster session. ACCP Annual Meeting. October 2010.
Globe D, Carlson J, Patel H, Colayco D, Hansen RN, Watanabe JH, Sullivan SD. Methodological considerations for cost-effectiveness analysis of onabotulinumtoxin A in patients with neurogenic detrusor overactivity.Poster session. International Society for Pharmacoeconomics and Outcomes Research International Meeting. May 2011.
Watanabe JH, Kazerooni R, Bounthavong M. Investigating the association between copayment status and adherence for statin medications in a veterans administration population. AMCP Annual Meeting. San Diego, CA. April 2013.
Watanabe JH, Sullivan SD. Impact of copayment escalations on simvastatin users: multi-year longitudinal assessment in the MarketScan Commercial Database. AMCP Annual Meeting. San Diego, CA. April 2013.
Watanabe JH, Bounthavong M, Chen T. Association of medication adherence levels and achievement of lipid goals. American Diabetes Association Scientific Sessions. Chicago, IL. June 2013.
Bounthavong M, Tran J, Watanabe JH, Chen T. Retrospective cohort study evaluating liraglutide and exenatide in a veteran population. International Society for Pharmacoeconomics and Outcomes Research International Meeting. New Orleans, LA. May 2013.
Ney JP, Watanabe JH. Effect of neurologist ambulatory visits on use of disease-specific pharmacotherapies for chronic neurological conditions. International Society for Pharmacoeconomics and Outcomes Research International Meeting. New Orleans, LA. May 2013.
Watanabe JH, Ney JP, Sullivan SD. Properties of propensity score matching procedures on covariate balancing and estimation: influence of the number of propensity score digits used on matched sets created. International Society for Pharmacoeconomics and Outcomes Research International Meeting. New Orleans, LA. May 2013.
Alfonso-Cristancho R, Watanabe JH. Are generic drugs defined and classified the same across the world. International Society for Pharmacoeconomics and Outcomes Research Latin America Conference. Buenos Aires, Argentina. September 13, 2013.
Carlson JJ, Watanabe JH, Boudreau D. Re: Abstract# 1627, Cost impact of OncotypeDx® breast cancer assay use in a fully integrated healthcare delivery system2013 San Antonio Breast Cancer Symposium. San Antonio, TX. December 10−14, 2013.
Accepted.
Chen T, Watanabe J, Cho S, Kazerooni R, Bounthavong M, Myers M. Evaluation of an intensive pharmacist managed telephone tobacco cessation clinic. Society for Research on Nicotine and Tobacco Annual Meeting. February 5-8, 2014.
Submitted.